These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20831915)

  • 1. Comment on the contribution by Weycker et al., "Cost of routine immunization of young children against rotavirus infection with Rotarix ® versus RotaTeq ®".
    Toumi M; Vesikari T; Giaquinto C
    Vaccine; 2010 Oct; 28(45):7241; author reply 7242. PubMed ID: 20831915
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq.
    Weycker D; Sofrygin O; Kemner JE; Pelton SI; Oster G
    Vaccine; 2009 Aug; 27(36):4930-7. PubMed ID: 19555715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of childhood rotavirus vaccination in Taiwan.
    Wu CL; Yang YC; Huang LM; Chen KT
    Vaccine; 2009 Mar; 27(10):1492-9. PubMed ID: 19186200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential epidemiological and economical impact of two rotavirus vaccines in Colombia.
    De la Hoz F; Alvis N; Narváez J; Cediel N; Gamboa O; Velandia M
    Vaccine; 2010 May; 28(22):3856-64. PubMed ID: 20347057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is it cost-effective to introduce rotavirus vaccination in the Dutch national immunization program?
    Mangen MJ; van Duynhoven YT; Vennema H; van Pelt W; Havelaar AH; de Melker HE
    Vaccine; 2010 Mar; 28(14):2624-35. PubMed ID: 20109593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the Netherlands.
    Goossens LM; Standaert B; Hartwig N; Hövels AM; Al MJ
    Vaccine; 2008 Feb; 26(8):1118-27. PubMed ID: 18215445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating rotavirus vaccination in England and Wales. Part II. The potential cost-effectiveness of vaccination.
    Jit M; Edmunds WJ
    Vaccine; 2007 May; 25(20):3971-9. PubMed ID: 17400341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel.
    Chodick G; Waisbourd-Zinman O; Shalev V; Kokia E; Rabinovich M; Ashkenazi S
    Eur J Public Health; 2009 Jun; 19(3):254-9. PubMed ID: 19221026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of rotavirus vaccination in Australia.
    Newall AT; Beutels P; Macartney K; Wood J; MacIntyre CR
    Vaccine; 2007 Dec; 25(52):8851-60. PubMed ID: 18022735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination.
    Shim E; Galvani AP
    Vaccine; 2009 Jun; 27(30):4025-30. PubMed ID: 19389452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the introduction of universal rotavirus vaccination in the Netherlands.
    Zomer TP; van Duynhoven YT; Mangen MJ; van der Maas NA; Vennema H; Boot H; de Melker HE
    Vaccine; 2008 Jul; 26(29-30):3757-64. PubMed ID: 18514975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of rotavirus vaccination: exploring caregiver(s) and "no medical care'' disease impact in Belgium.
    Bilcke J; Van Damme P; Beutels P
    Med Decis Making; 2009; 29(1):33-50. PubMed ID: 18948433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Active immunization against acute gastro-enteritis among young children, caused by rotaviruses].
    Magdzik W
    Przegl Epidemiol; 2007; 61(4):723-31. PubMed ID: 18572504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated research and development costs of rotavirus vaccines.
    Light DW; Andrus JK; Warburton RN
    Vaccine; 2009 Nov; 27(47):6627-33. PubMed ID: 19665605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai children.
    Chotivitayatarakorn P; Chotivitayatarakorn P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2010 Jan; 41(1):114-25. PubMed ID: 20578490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotavirus vaccines: entering a new stage of deployment.
    Nakagomi O; Cunliffe NA
    Curr Opin Infect Dis; 2007 Oct; 20(5):501-7. PubMed ID: 17762784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live attenuated human rotavirus vaccine, Rotarix.
    Bernstein DI
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):188-94. PubMed ID: 17055369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost and cost-effectiveness of childhood vaccination against rotavirus in France.
    Melliez H; Levybruhl D; Boelle PY; Dervaux B; Baron S; Yazdanpanah Y
    Vaccine; 2008 Jan; 26(5):706-15. PubMed ID: 18166250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine.
    ;
    Pediatrics; 2009 May; 123(5):1412-20. PubMed ID: 19332437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-benefit analysis of a rotavirus immunization program in the Arab Republic of Egypt.
    Ortega O; El-Sayed N; Sanders JW; Abd-Rabou Z; Antil L; Bresee J; Mansour A; Adib I; Nahkla I; Riddle MS
    J Infect Dis; 2009 Nov; 200 Suppl 1():S92-8. PubMed ID: 19817621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.